Purple pleural fluid secondary to Acinetobacter baumannii infection

• Published in: BMJ case reports Vol. 16; no. 10; p. e255719
• Main Authors: Agarwal, Ketan, Biswas, Ratnadeep, Kirti, Ravi
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group LTD 12.10.2023
• Subjects: Acinetobacter baumannii; Acinetobacter Infections - diagnosis; Acinetobacter Infections - drug therapy; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Bacterial infections; Case reports; Cross Infection - drug therapy; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Hemodialysis; Humans; Infections; Metabolites; Phosphatase; Respiratory System; Empyema; TB and other respiratory infections; Infectious diseases; Pleural infection; General practice / family medicine
• ISSN: 1757-790X; 1757-790X
• DOI: 10.1136/bcr-2023-255719

Analysis of the pleural fluid revealed 7–10 pus cells per low power field and Gram-negative cocco-bacilli. The patient was continued on antitubercular therapy, and intravenous colistin (loading dose of 300 mg of colistin base activity (CBA), followed by a maintenance dose of 180 mg CBA on haemodialysis days and 130 mg CBA on non-dialysis days) and intravenous meropenem (loading dose of 1 g given over 30 min, followed by 500 mg given over 3 hours by the extended infusion method on haemodialysis days) were added. Contributors All authors were responsible for the drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms, critical revision for important intellectual content, patient care and final approval of the manuscript.